A New Treatment to Fight Ovarian Cancer has been Developed by UCLA Scientists
- February 23, 2026
Cabaletta Bio Advances Rare Disease Treatment with Pioneering Myositis Trial and Innovative Manufacturing Breakthrough
After the Diagnosis: Self-Harming Thoughts and So Many Questions
Thriving Is a Choice: How Community, Boundaries, and Mindfulness Saved My Life & Thyroid
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Cabaletta Bio Advances Rare Disease Treatment with Pioneering Myositis Trial and Innovative Manufacturing Breakthrough bit.ly/4c3yRIi Read now at PatientWorthy.com
#PatientWorthy #myositis #clinicaltrial
Cutaneous squamous cell carcinoma is one of the most common types of skin cancer, affecting millions of people each year. While many cases are treatable, awareness is key because this cancer can become serious if not addressed.
Protecting your skin, staying informed, and prioritizing regular medical care all play an important role in reducing risk and improving outcomes. Education and awareness saves lives! If you have a story to share, click here: bit.ly/4dV7gru
#CSCC #skincancer #skincancerawareness #shareyourstory #PatientWorthy
During Rare Disease Month, Patient Worthy is honored to share a story from Joanna who has been diagnosed with Primary Immunodeficiency (PI).
"My name is Joanna and I have been living with a rare primary immune deficiency disease my whole life. I turn 54 this month. I've been blessed in that my condition has an effective FDA approved treatment called immune globulin. It basically gives me a temporary immune system. I get infusions every week. I know so many rare diseases do not yet have an effective treatment and that is one reason it is so important for all of us to show our stripes and raise awareness. Every rare disease patient should have the help they need to live as healthy a life as possible. Together we are stronger."
#RareDiseaseMonth #RareDisease #RareButNotAlone #WeCareAboutRare #ShareYourStripes #ShareYourStory #PatientWorthy #PrimaryImmunodeficiency
